Jasmine Blane

Jasmine Blane

Auto-generated profile, based on publicly available information

Jasmine Blane

Oxford Health NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2020 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
CLClaire Lancaster
Claire Lancaster
IKIvan Koychev
Ivan Koychev
JBJasmine Blane
Jasmine Blane
ACAmy Chinner
Amy Chinner
LWLeona Wolters
Leona Wolters
CHChris Hinds
Chris Hinds
Background: By enabling frequent, sensitive, and economic remote assessment, smartphones will facilitate the detection of early cognitive decline at scale. Previous studies have sustained participant engagement with remote cognitive assessment over a week; extending this to a period of 1 month clearly provides a greater opportunity for measurement. However, as study durations are increased, the need to understand how participant burden and scientific value might be optimally balanced also increases. Objective: This study explored the little but often approach to assessment employed by the Mezurio app when prompting participants to interact every day for over a month. Specifically, this study aimed to understand whether this extended duration of remote study is feasible, and which factors promote sustained participant engagement over such periods. Methods: A total of 35 adults (aged 40-59 years) with no diagnosis of cognitive impairment were prompted to interact with the Mezurio smartphone app platform for up to 36 days, completing short, daily episodic memory tasks in addition to optional executive function and language tests. A subset (n=20) of participants completed semistructured interviews focused on their experience of using the app. Results: Participants complied with 80% of the daily learning tasks scheduled for subsequent tests of episodic memory, with 88% of participants still actively engaged by the final task. A thematic analysis of the participants’ experiences highlighted schedule flexibility, a clear user interface, and performance feedback as important considerations for engagement with remote digital assessment. Conclusions: Despite the extended study duration, participants demonstrated high compliance with the schedule of daily learning tasks and were extremely positive about their experiences. Long durations of remote digital interaction are therefore definitely feasible but only when careful attention is paid to the design of the users’ experience.

20 April 2018 in Evidence Based Mental Health
Verified
Journal Article
Closed access
PDF file
ACAmy Chinner
Amy Chinner
JBJasmine Blane
Jasmine Blane
CLClaire Lancaster
Claire Lancaster
CHChris Hinds
Chris Hinds
IKIvan Koychev
Ivan Koychev
Dementia is the most widespread form of neurodegenerative disorder and is associated with an immense societal and personal cost. Prevalence of this disorder is projected to triple worldwide by 2050 leading to an urgent need to make advances in the efficiency of both its care and therapy research. Digital technologies are a rapidly advancing field that provide a previously unavailable opportunity to alleviate challenges faced by clinicians and researchers working in this area. This clinical review aimed to summarise currently available evidence on digital technologies that can be used to monitor cognition. We identified a range of pervasive digital systems, such as smartphones, smartwatches and smart homes, to assess and assist elderly demented, prodromal and preclinical populations. Generally, the studies reported good level of agreement between the digital measures and the constructs they aimed to measure. However, most of the systems are still only in the initial stages of development with limited data on acceptability in patients. Although it is clear that the use of digital technology to monitor and support the cognitive domains affected by dementia is a promising area of development, additional research validating the efficacy, utility and cost-effectiveness of these systems in patient populations is needed.

1 July 2021 in Respiratory Medicine
Verified
Journal Article
Closed access
LML.C. Marsh
L.C. Marsh
RLR.M. Leach
R.M. Leach
JBJ. Blane
J. Blane
KDK. Daly
K. Daly
NBN.A. Barrett
N.A. Barrett
MKM D Kopelman
M D Kopelman

4 April 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
CLClaire Lancaster
Claire Lancaster
IKIvan Koychev
Ivan Koychev
JBJasmine Blane
Jasmine Blane
ACAmy Chinner
Amy Chinner
CCChristopher Chatham
Christopher Chatham
CHChris Hinds
Chris Hinds
Gallery Game, deployed within the Mezurio smartphone app, targets the processes of episodic memory first vulnerable to neurofibrillary tau-related degeneration in Alzheimer’s Disease, prioritising both perirhinal and entorhinal cortex/hippocampal demands. Thirty-five healthy adults (aged 40-59 years), biased towards those at elevated familial risk of dementia, completed daily Gallery Game tasks for a month. Assessments consisted of cross-modal paired-associate learning, with subsequent tests of recognition and recall following delays ranging from one to 13 days. There was a non-linear decline in memory retention with increasing delays between learning and test, with significant forgetting first reported following delays of three and five days for paired-associate recall and recognition respectively, supporting the need for ecologically valid measures of longer-term memory. Gallery Game outcomes correlated as expected with established neuropsychological memory assessments, confirming the validity of this digital assessment of episodic memory. In addition, there was preliminary support for utilising the perirhinal-dependent pattern of semantic errors during object recognition as a marker of early impairment, justifying ongoing validation against traditional biomarkers of Alzheimer’s disease.

4 September 2019 in medRxiv
Verified
Preprint
Open access
PDF file
CLClaire Lancaster
Claire Lancaster
JBJasmine Blane
Jasmine Blane
ACAmy Chinner
Amy Chinner
LWLeona Wolters
Leona Wolters
IKIvan Koychev
Ivan Koychev
CHChris Hinds
Chris Hinds
Background: Smartphones may significantly contribute to the detection of early cognitive decline at scale by enabling remote, frequent, sensitive, economic assessment. Several prior studies have sustained engagement with participants remotely over a period of a week; extending this to a period of a month would clearly give greater opportunity for measurement. However, as such study durations are increased, so too is the need to understand how participant burden and scientific value might be optimally balanced. Objectives: We explore the ‘little but often’ approach to assessment employed by the Mezurio app, interacting with participants every day for over a month. We aim to understand whether this extended remote study duration is feasible, and which factors might promote sustained participant engagement over such study durations. Methods: Thirty-five adults (aged 40-59 years) with no diagnosis of cognitive impairment were prompted to interact with the Mezurio smartphone app platform for up to 36 days, completing short, daily episodic memory tasks in addition to optional executive function and language tests. A subset ( n =20) completed semi-structured interviews focused on their experience using the app. Results: Average compliance with the schedule of learning for subsequent memory test was 80%, with 88% of participants still actively engaged by the final task. Thematic analysis of participants’ experiences highlighted schedule flexibility, a clear user-interface, and performance feedback as important considerations for engagement with remote digital assessment. Conclusions: Despite the extended study duration, participants demonstrated high compliance with the tasks scheduled and were extremely positive about their experiences. Long durations of remote digital interaction are therefore definitely feasible, but only when careful attention is paid to the design of the users’ experience.

31 December 2021 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
JBJasmine Blane
Jasmine Blane
MCM ClareO'Donoghue
M ClareO'Donoghue
ECEmma Craig
Emma Craig
LCLaura Clarke
Laura Clarke
VRVanessa Raymont
Vanessa Raymont
LMLola Martos
Lola Martos